Camp Lejeune cancer lawsuit

Lawsuits Could Hold 3M And Others Accountable For Camp Lejeune Water Cancer

Dozens of military bases throughout the country used AFF foam to extinguish jet fuel and petroleum fires and trained with it

Saturday, October 22, 2022 - A Camp Lejeune PFAS water lawsuit was filed earlier this month in U.S. District Court for the District of South Carolina alleging that 3M and a dozen other companies knew the dangers of AFF firefighting foam and failed to warn consumers. Dozens of military bases throughout the country used AFF foam to extinguish jet fuel and petroleum fires and trained with it regularly. Firefighting foam contains PFAS forever chemicals that have strong internal molecular bonds that do not break down in the human body or environment allowing toxins to bioaccumulate. Millions of people worked, lived, or otherwise consumed the Camp Lejeune drinking water for decades. Thousands of people have developed cancer or other diseases as a result. Camp Lejeune water contamination is also blamed for causing miscarriages, birth defects, and stillbirths from mothers who drank the water on the base while pregnant.

The Camp Lejeune Justice Act allows US Marines, other servicemembers, civilian employees and contractors, and their family members, to file a Camp Lejeune Justice Act Claim seeking lump-sum monetary compensation from the federal government for the financial losses they suffered. The loss may have stemmed from not being able to continue to work at a job or a profession or occupation the plaintiff desired, and the loss of income that resulted. Most people who file a claim may look for millions of dollars in compensation. One is advised to consult a Camp Lejeune Justice Act claim attorney to make sure the application is filled out correctly, all corresponding documentation is collected and presented, and most importantly, that the dollar amount accurately reflects the plaintiff's monetary damages. Failure to accomplish any of these three objectives may result in the claim being rejected unnecessarily and delay payment or reduce the payment accordingly. Those injured by drinking Camp Lejeune water may also file a Camp Lejeune water lawsuit against DuPont, 3M, and about one dozen other companies that manufactured firefighting foam containing PFAS forever chemicals. The other day, the US Attorney General in Raleigh, North Carolina filed a lawsuit alleging that the companies that manufactured the firefighting foam used at Camp Lejeune and elsewhere for decades contained toxic, carcinogenic PFAS forever chemicals that were disposed of into the local water tables improperly. This resulted in Camp Lejeune water contamination even greater than that which the Department of Defense admits took place concerning volatile organic compounds, benzene, and fluorine contaminating the water. Camp Lejeune PFAS water lawsuits may not only seek compensation for monetary losses but also for punitive damages that could be tenfold greater than the initial amount. Punitive damages seek to not only compensate the injured plaintiff for their suffering but also punish the company for their reprehensible corporate conduct, a means of satisfaction not granted under the Camp Lejeune Justice Act. "In our filing with the court, we allege that these companies that made firefighting foam knew well how dangerous it was to our first responders and our natural resources," (AG) Stein said in a statement. "But they continued to sell this product to line their pockets at the expense of our health and our drinking water," according to Bloomberg."

Information provided by CampLejeuneJusticeActClaim.com, a website devoted to providing news about Camp Lejeune Justice Act Claim, including a free no-cost, no-obligation Camp Lejeune Justice Act Claim.

More Recent Camp Lejeune Water Lawsuit News:

View all Camp Lejeune Justice Act Claim News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer After Spending 30 Days or More at Camp Lejeune between 1953 and 1988

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.